Pfizer to spin off animal health business

Pharma giant Pfizer has taken the first steps towards spinning off its animal health business. It has been announced that preparations are underway to file for a potential stock market launch of the new firm. The standalone company name – Zoetis – was announced at the same time.

Pfizer’s animal health business has 9000 employees and markets products in over 120 different countries. In 2011, it generated sales of about $4.2 billion (£2.7 billion).

Zoetis is expected to start trading in July 2013. The company plans to give further details as part of its second quarter profit announcement.


Related Content

Zoetis IPO launches at $2.2bn

1 February 2013 Business

news image

Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh

Business roundup

29 September 2011 Business

news image

Industry news, October 2011

Most Read

Sugar solution to toxic gold recovery

15 May 2013 Research

news image

The environmental legacy of salvaging gold from electronic waste can be dramatically cut using corn starch instead of cyanide

Canada’s research council is open – for business

14 May 2013 News and Analysis

news image

Government plans to turn scientific body into a 'tool for industry' leading to fears basic research will be sidelined

Most Commented

Step towards a spider venom vaccine

13 May 2013 Research

news image

Engineered protein can be used to produce antivenoms and might provide long-lasting protection against bites

3D printer churns out bionic ear

17 May 2013 Research

news image

Seamless integration of electronics and tissue could be used with other artificial implants and synthetic organs